|

Intravital Microscopy in Human Solid Tumors

RECRUITINGN/ASponsored by Mayo Clinic
Actively Recruiting
PhaseN/A
SponsorMayo Clinic
Started2019-02-28
Est. completion2026-09-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This study will investigate the tumor-associated vasculature of patients with solid tumors. The investigators will use a technology known as intravital microscopy (IVM) in order to visualize in real-time the vessels associated with solid tumors. The IVM observations may determine if an individual patient's tumor vessels would be amenable to receiving systemic therapy, based on the functionality of the vessels.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 18 years of age
* Eastern Cooperative Oncology Group (ECOG)Performance Status of ≤ 2
* Measurable tumor by direct visualization requiring surgical resection in the operating room (OR)
* Tumor types of origin include gastric, pancreatic, hepatobiliary, colorectal, sarcoma, brain, or breast cancer that may involve the axillary lymph nodes cancers. Tumors may be primary or metastatic
* Subject must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent
* Subject must have a skin prick test pre-operatively (at the time of the preoperative visit and after signed informed consent for entry into this clinical trial is given) to determine any sensitivity to fluorescein

Exclusion Criteria:

* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations
* Renal dysfunction as defined as a glomerular filtration rate (GFR) \< 45
* Liver dysfunction as defined by Child-Pugh score \> 5, or liver function test (LFT)'s 1.5 x above normal range
* Any known allergy or prior reaction to fluorescein or a positive skin prick test to fluorescein
* Pregnant or nursing female subjects, determined preoperatively with a urine pregnancy test
* Unwilling or unable to follow protocol requirements
* Any condition which in the investigators' opinion deems the patient unsuitable (e.g., abnormal electrocardiography \[EKG\], including T wave inversion, elevated T waves, prolonged QRS interval, or conduction blocks) or that requires further work-up (including cardiac echo or stress test)
* Any condition that excludes surgical resection as the standard of care for the patient

Conditions27

Anatomic Stage IV Breast Cancer AJCC v8Breast CancerCancerClinical Stage IV Gastric Cancer AJCC v8Liver CancerLiver DiseaseMalignant Brain NeoplasmMalignant Solid NeoplasmMetastatic Breast CarcinomaMetastatic Colorectal Carcinoma

Locations1 site

Mayo Clinic Florida
Jacksonville, Florida, 32224
Emmanuel M Gabriel, M.D., Ph. D.904-953-2523gabriel.emmanuel@mayo.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.